Business Description
Hansoh Pharmaceutical Group Co Ltd
ISIN : KYG549581067
Total Employee Number:
9,347Compare
Compare
Traded in other countries / regions
03692.Hong KongHANSOH19.Thailand3KY.GermanyHNSPF.USA IPO Date
2021-02-11Description
Hansoh Pharmaceutical Group Co Ltd is an investment holding company. The company were principally engaged in the research and development, production and sale of a series of pharmaceutical products in the People's Republic of China. It focuses on disease therapeutic areas such as oncology, anti-infectives, CNS, metabolism and immunology. The majority of Group's revenue was generated from the sale of pharmaceutical products in Chinese mainland.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 300.37 | |||||
Equity-to-Asset | 0.89 | |||||
Debt-to-EBITDA | 0.02 | |||||
Interest Coverage | 1753.13 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 26.9 | |||||
Beneish M-Score | -2.66 | |||||
WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 16.3 | |||||
3-Year EBITDA Growth Rate | 26.7 | |||||
3-Year EPS without NRI Growth Rate | 29.1 | |||||
3-Year FCF Growth Rate | 35.8 | |||||
3-Year Book Growth Rate | 14.7 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 9.38 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 11.49 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 0.01 | |||||
9-Day RSI | 0.35 | |||||
14-Day RSI | 2.09 | |||||
3-1 Month Momentum % | -13 | |||||
6-1 Month Momentum % | -9.77 | |||||
12-1 Month Momentum % | 11.25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 8.09 | |||||
Quick Ratio | 7.95 | |||||
Cash Ratio | 7.18 | |||||
Days Inventory | 153.82 | |||||
Days Sales Outstanding | 71.34 | |||||
Days Payable | 66.16 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 1.23 | |||||
Dividend Payout Ratio | 0.36 | |||||
3-Year Dividend Growth Rate | 39.4 | |||||
Forward Dividend Yield % | 1.45 | |||||
5-Year Yield-on-Cost % | 1.23 | |||||
3-Year Average Share Buyback Ratio | -0.7 | |||||
Shareholder Yield % | -0.86 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 90.03 | |||||
Operating Margin % | 36.88 | |||||
Net Margin % | 36.94 | |||||
EBITDA Margin % | 46.19 | |||||
FCF Margin % | 41.54 | |||||
OCF Margin % | 44.8 | |||||
ROE % | 17.65 | |||||
ROA % | 15.75 | |||||
ROIC % | 70.04 | |||||
3-Year ROIIC % | -809.65 | |||||
ROC (Joel Greenblatt) % | 179.78 | |||||
ROCE % | 20.65 | |||||
Years of Profitability over Past 10-Year | 10 | |||||
Moat Score | 5 | |||||
Tariff Resilience Score | 4 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 33.01 | |||||
Forward PE Ratio | 26.56 | |||||
PE Ratio without NRI | 32.85 | |||||
Shiller PE Ratio | 59.9 | |||||
Price-to-Owner-Earnings | 25.32 | |||||
PEG Ratio | 2.53 | |||||
PS Ratio | 12.21 | |||||
PB Ratio | 5.22 | |||||
Price-to-Tangible-Book | 5.24 | |||||
Price-to-Free-Cash-Flow | 29.36 | |||||
Price-to-Operating-Cash-Flow | 27.22 | |||||
EV-to-EBIT | 21.51 | |||||
EV-to-Forward-EBIT | 24.12 | |||||
EV-to-EBITDA | 20.29 | |||||
EV-to-Revenue | 9.37 | |||||
EV-to-Forward-Revenue | 7.96 | |||||
EV-to-FCF | 22.56 | |||||
Price-to-GF-Value | 1.28 | |||||
Price-to-Projected-FCF | 2.85 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.5 | |||||
Price-to-Graham-Number | 2.77 | |||||
| Price-to-Net-Current-Asset-Value | 5.98 | |||||
| Price-to-Net-Cash | 6.83 | |||||
Earnings Yield (Greenblatt) % | 4.65 | |||||
FCF Yield % | 3.36 | |||||
Forward Rate of Return (Yacktman) % | 14.66 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:HNSPF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hansoh Pharmaceutical Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 2,113.569 | ||
| EPS (TTM) ($) | 0.131 | ||
| Beta | -0.5618 | ||
| 3-Year Sharpe Ratio | 0.83 | ||
| 3-Year Sortino Ratio | 1.77 | ||
| Volatility % | 43.85 | ||
| 14-Day RSI | 2.09 | ||
| 14-Day ATR ($) | 0.016764 | ||
| 20-Day SMA ($) | 3.9246 | ||
| 12-1 Month Momentum % | 11.25 | ||
| 52-Week Range ($) | 3.825 - 5.2 | ||
| Shares Outstanding (Mil) | 6,062.96 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hansoh Pharmaceutical Group Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hansoh Pharmaceutical Group Co Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| HKD 0.200000 Cash Dividend | 2026-07-06 | In 3 days | ||
| HKD 0.231600 Cash Dividend | 2025-09-22 | 4.50 (+0.00%) | ||
| HKD 0.135300 Cash Dividend | 2025-07-03 | 4.04 (+0.00%) | ||
| HKD 0.201000 Cash Dividend | 2024-09-20 | 1.88 (+0.00%) |
Show
Entries
Hansoh Pharmaceutical Group Co Ltd Frequently Asked Questions
What is Hansoh Pharmaceutical Group Co Ltd(HNSPF)'s stock price today?
The current price of HNSPF is $3.83. The 52 week high of HNSPF is $5.20 and 52 week low is $3.83.
When is next earnings date of Hansoh Pharmaceutical Group Co Ltd(HNSPF)?
The next earnings date of Hansoh Pharmaceutical Group Co Ltd(HNSPF) is .
Does Hansoh Pharmaceutical Group Co Ltd(HNSPF) pay dividends? If so, how much?
The Dividend Yield %  of Hansoh Pharmaceutical Group Co Ltd(HNSPF) is 1.23% (As of Today), Highest Dividend Payout Ratio of Hansoh Pharmaceutical Group Co Ltd(HNSPF) was 0.43. The lowest was 0.15. And the median was 0.29. The  Forward Dividend Yield % of Hansoh Pharmaceutical Group Co Ltd(HNSPF) is 1.45%. For more information regarding to dividend, please check our Dividend Page.
Guru Commentaries on OTCPK:HNSPF
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Hansoh Pharmaceutical Group Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers